Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients
Clinical trial NCT02109744 · COMPLETED
Trial details
- NCT number
- NCT02109744
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2022-01-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.